August
3
TriSalus Life Sciences Acquires Dynavax’s SD-101 Oncology Program
Purchase agreement for up to $250 million in milestone payments plus royalties on future...
News
Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.